Sean D. Sullivan
The fertility of our minds to invent health care technology must now be matched by a commitment to assess and identify its appropriate use.
EducationPhD University of California (Berkeley), 1992 (Health Economics)
MS University of Texas (Austin), 1986 (Pharmacy)
BS Oregon State University, 1983 (Pharmacy)
Contact Infoemail: firstname.lastname@example.org
office: H-375, Health Sciences Building
1959 NE Pacific Street
Seattle, WA 98195-7630
campus box: 357630
Sean D. Sullivan is Professor and Dean of the University of Washington School of Pharmacy. In addition to his joint appointment as Professor of Health Services, He also holds adjunct appointments in the School of Medicine, the Public Health Sciences Division at the Fred Hutchinson Cancer Research Center, and at Kaiser Permanente Washington Health Research Institute.
Dr. Sullivan has authored more than 300 journal articles, book chapters, task force reports and organizational and governmental publications. In many of these writings, he has assessed the evidence and applications of medical technology in relation to coverage and reimbursement decisions. His research interests include technology assessment, medical decision-making and economic evaluation of medical technology. He is the past chair of the Academy of Managed Care Pharmacy executive committee on the AMCP Format for Formulary Submissions - the United States evidence-based guidelines for formulary decision-making.
Dr. Sullivan is a member of the Medicare Evidence Development and Coverage Advisory Committee. He is also on the editorial boards of Value in Health, PharmacoEconomics, European Journal of Health Economics and Core Evidence. He is a past president of the International Society for Pharmacoeconomics and Outcomes Research.
Canestaro WJ, Hendrix N, Bansal A, Sullivan SD, Devine EB, Carlson JJ. Favorable and publicly funded studies are more likely to be published: a systematic review and meta-analysis. J Clin Epidemiol. 2017 Aug 31. pii: S0895-4356(17)30134-8. doi: 10.1016/j.jclinepi.2017.08.004. [Epub ahead of print] Review. PMID: 28842289
Slejko JF, Basu A, Sullivan SD. Returns to scientific publications for pharmaceutical products in the United States. Health Econ. 2017 Jul 10. doi: 10.1002/hec.3546. [Epub ahead of print] PMID: 28695605
Bansal A, Sullivan SD, Hershman DL, Lyman GH, Barlow WE, McCune JS, Ramsey SD. A stakeholder-informed randomized, controlled comparative effectiveness study of an order prescribing intervention to improve colony stimulating factor use for cancer patients receiving myelosuppressive chemotherapy: the TrACER study. J Comp Eff Res. 2017 Jul;6(5):461-470. doi: 10.2217/cer-2017-0005. Epub 2017 Jul 7. PMID: 28686055
Yeung K, Basu A, Hansen RN, Watkins JB, Sullivan SD. Impact of a Value-based Formulary on Medication Utilization, Health Services Utilization, and Expenditures. Med Care. 2017 Feb;55(2):191-198. doi: 10.1097/MLR.0000000000000630. PMID: 27579915
- Cancer drug prices climb after market launch (Health Affairs, 05/10/2016)
- Sean D. Sullivan Named Dean of UW School of Pharmacy
- Steroid Injections Offer Little Relief for Spinal Stenosis
- Why Is It So Hard To Find The Price Of A Medical Procedure?
- Heroin Overdose Antidote Kits Cost Effective